Week in Washington

The House approved H.R. 1540, the National Defense Authorization Act, which includes an amendment that would finally reauthorize the SBIR program and would allow up to 25 percent of SBIR grants to go to companies that are majority owned by multiple venture capitalists.

An FDA advisory committee debated how to test smallpox drugs under the animal rule when no animal model of the disease exists.